Additional top-ranked genes included NSD2, an epigenetic regulator implicated in pulmonary arterial hypertension65 and RAS/MAPK pathway genes BRAF, RAF1, and PTPN11, which drive Noonan syndrome and other RASopathies associated with CHD. This evidence concerns the gene NSD2 and RASopathy.